Cefdinir is a third-generation cephalosporin antibiotic that helps treat bacterial infections such as respiratory tract infections, skin infections, and some ear infections. It works by disrupting the formation of bacterial cell walls, effectively eliminating harmful bacteria. Known in the UK for its broad-spectrum activity, Cefdinir is often used when other antibiotics may not be suitable. Its effectiveness and tolerability make it a well-recognised option in antimicrobial therapy in the UK and all over hte world.
Bronchitis
Moxifloxacin
Moxifloxacin is a fluoroquinolone antibiotic used in the UK primarily for treating bacterial infections, including respiratory and skin infections. It is particularly significant in the management of tuberculosis (TB), especially for drug-resistant strains. It is recognized for its effectiveness and safety in various clinical settings in the UK.